A qualitative study of medication adherence amongst people with schizophrenia.

[1]  Susan R. Jones,et al.  Negotiating the Complexities of Qualitative Research in Higher Education , 2021 .

[2]  Edward Kim,et al.  Projecting the Long-Term Economic Impact of Once-Monthly Paliperidone Palmitate Versus Oral Atypical Antipsychotics in Medicaid Patients with Schizophrenia , 2020, Journal of managed care & specialty pharmacy.

[3]  A. Tanskanen,et al.  Adherence to psychotropic medication in completed suicide in Sweden 2006–2013: a forensic-toxicological matched case-control study , 2019, European Journal of Clinical Pharmacology.

[4]  Chan-Hyung Kim,et al.  Association between Therapeutic Alliance and Adherence in Outpatient Schizophrenia Patients , 2019, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

[5]  M. Salzmann-Erikson,et al.  A narrative meta-synthesis of how people with schizophrenia experience facilitators and barriers in using antipsychotic medication: Implications for healthcare professionals. , 2018, International journal of nursing studies.

[6]  A. Buchanan.  Compliance With Treatment In Schizophrenia , 2018 .

[7]  H. Grabe,et al.  Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla) , 2018, BMC Psychiatry.

[8]  D. Beeckman,et al.  Constructing a positive identity: A qualitative study of the driving forces of peer workers in mental health-care systems. , 2018, International journal of mental health nursing.

[9]  R. Kahn,et al.  Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies , 2015, European Neuropsychopharmacology.

[10]  D. Tracy,et al.  A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders , 2015, Psychiatry Research.

[11]  R. Silverman,et al.  Semi-Structured Interviewing , 2014, Qualitative Research Methods for Community Development.

[12]  D. Wiersma,et al.  Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. , 2013, JAMA psychiatry.

[13]  M. De Hert,et al.  Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review , 2013, Therapeutic advances in psychopharmacology.

[14]  P. Thomas.  [Pharmacological treatment of schizophrenia]. , 2013, La Revue du praticien.

[15]  Moon-Soo Lee,et al.  Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophrenia , 2012, Schizophrenia Research.

[16]  O. Andreassen,et al.  Predictors of medication adherence in patients with schizophrenia and bipolar disorder , 2012, Acta psychiatrica Scandinavica.

[17]  D. Linszen,et al.  Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–A review of the past decade , 2012, European Psychiatry.

[18]  D. Goff,et al.  Becoming adherent to antipsychotics: a qualitative study of treatment-experienced schizophrenia patients. , 2011, Psychiatric services.

[19]  E. Torrey.  Patients, clients, consumers, survivors et al: what's in a name? , 2011, Schizophrenia bulletin.

[20]  L. Boyer,et al.  Factors Associated with Medication Non-Adherence in Patients Suffering from Schizophrenia: A Cross-Sectional Study in a Universal Coverage Health-Care System , 2010, The Australian and New Zealand journal of psychiatry.

[21]  Josep Maria Haro,et al.  Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia , 2010, Psychiatry Research.

[22]  B. Schneider.  Hearing (our) Voices: Participatory Research in Mental Health , 2010 .

[23]  E. O'callaghan,et al.  First episode psychosis and the trail to secondary care: help-seeking and health-system delays , 2010, Social Psychiatry and Psychiatric Epidemiology.

[24]  D. Naber,et al.  Cure or Curse? Ambivalent Attitudes Towards Neuroleptic Medication in Schizophrenia and Non-Schizophrenia Patients , 2009, Mental illness.

[25]  Thomas E. Smith,et al.  Schizophrenia (maintenance treatment). , 2009, BMJ clinical evidence.

[26]  E. Susser,et al.  New directions in the epidemiology of schizophrenia , 2009, The Medical journal of Australia.

[27]  W. Dubin,et al.  Medication Adherence: A Review of the Literature and Implications for Clinical Practice , 2009, Journal of psychiatric practice.

[28]  A. Beck,et al.  Schizophrenia: Cognitive Theory, Research, and Therapy , 2008 .

[29]  M. Lambert,et al.  Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. , 2008, Journal of psychiatric research.

[30]  J. Lieberman,et al.  CATIE and CUtLASS: can we handle the truth? , 2008, British Journal of Psychiatry.

[31]  Ashley A. Miles,et al.  Predictors of medication competence in schizophrenia patients , 2008, Psychiatry Research.

[32]  Kelly Hunter,et al.  Mental health peer support for hospital avoidance and early discharge: An Australian example of consumer driven and operated service , 2008 .

[33]  T. Lincoln,et al.  Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: A meta-analysis , 2007, Schizophrenia Research.

[34]  G. Swaminath,et al.  You can lead a horse to the water…. , 2007, Indian journal of psychiatry.

[35]  D. Perlick.  The Complete Family Guide to Schizophrenia , 2007 .

[36]  Sarah J. Shoemaker,et al.  Understanding the meaning of medications for patients: The medication experience , 2007, Pharmacy World & Science.

[37]  F. Baum,et al.  Participatory action research , 2006, Journal of Epidemiology and Community Health.

[38]  Christian R. Dolder,et al.  A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. , 2006, The Journal of clinical psychiatry.

[39]  Fiona Wood,et al.  Keywords in Qualitative Methods: A Vocabulary of Research Concepts , 2006 .

[40]  W. Gaebel,et al.  Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders , 2006, Psychopharmacology.

[41]  Larry Davidson,et al.  Peer Support Among Individuals with Severe Mental Illness , 2006 .

[42]  Jacqueline L Johnson,et al.  Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode , 2006, Schizophrenia Research.

[43]  Stefan Leucht,et al.  Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. , 2006, The American journal of psychiatry.

[44]  Graham Martin,et al.  Australian e-Journal for the Advancement of Mental Health , 2005 .

[45]  G. Thornicroft,et al.  Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. , 2005, Schizophrenia bulletin.

[46]  R. Gray,et al.  A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. , 2005, Journal of advanced nursing.

[47]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[48]  R. Freedman.  The choice of antipsychotic drugs for schizophrenia. , 2005, The New England journal of medicine.

[49]  M. Marcolin,et al.  Evaluation of the factors interfering with drug treatment compliance among Brazilian patients with schizophrenia. , 2005, Revista brasileira de psiquiatria.

[50]  A. Green.  Schizophrenia and comorbid substance use disorder: effects of antipsychotics. , 2005, The Journal of clinical psychiatry.

[51]  P. Leavy,et al.  The Practice of Qualitative Research , 2005 .

[52]  R. Bentall,et al.  Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. , 2005, Archives of general psychiatry.

[53]  R. Liberman,et al.  Recovery from schizophrenia: a concept in search of research. , 2005, Psychiatric services.

[54]  S-71. Symposium: The QUATRO study — an European randomised controlled trial of compliance therapy , 2005, European Psychiatry.

[55]  M. Lambert,et al.  Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence , 2004, European Psychiatry.

[56]  R. Rosenheck,et al.  An exploratory analysis of correlates of recovery. , 2004, Psychiatric services.

[57]  Sukanta Saha,et al.  A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology , 2004, BMC medicine.

[58]  G. Blashki,et al.  Managing schizophrenia in general practice. , 2004, Australian family physician.

[59]  R. Powell,et al.  The quest for well-being: a qualitative study of the experience of taking antipsychotic medication. , 2004, Psychology and psychotherapy.

[60]  G. Shean.  Understanding and Treating Schizophrenia: Contemporary Research, Theory, and Practice , 2004 .

[61]  Xiaotong Han,et al.  A pilot study of barriers to medication adherence in schizophrenia. , 2004, The Journal of clinical psychiatry.

[62]  R. Bentall,et al.  Patients’ understanding and participation in a trial designed to improve the management of anti-psychotic medication , 2003, Social Psychiatry and Psychiatric Epidemiology.

[63]  G. Donohoe,et al.  Compliance therapy: a randomised controlled trial in schizophrenia , 2003, BMJ : British Medical Journal.

[64]  N. Vuckovic,et al.  Negotiating medications: patient perceptions of long‐term medication use , 2003, Journal of clinical pharmacy and therapeutics.

[65]  C. Correll,et al.  Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. , 2003, The American journal of psychiatry.

[66]  Christian R. Dolder,et al.  Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. , 2002, The Journal of clinical psychiatry.

[67]  T. Wykes,et al.  From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication. , 2002, Journal of psychiatric and mental health nursing.

[68]  J. Endicott,et al.  The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study , 2002, European Neuropsychopharmacology.

[69]  B. Svarstad,et al.  Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. , 2001, Psychiatric services.

[70]  J. Geller.  Personal accounts: first-person accounts in the Journal's second 25 years , 2000 .

[71]  M. Olfson,et al.  Predicting medication noncompliance after hospital discharge among patients with schizophrenia. , 2000, Psychiatric services.

[72]  R. Ross,et al.  Breakthroughs in Antipsychotic Medications: A Guide for Consumers, Families, and Clinicians , 1999 .

[73]  J. Lieberman,et al.  Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. , 1999, Archives of general psychiatry.

[74]  M. Pitman.  Qualitative Research Design: An Interactive Approach , 1998 .

[75]  R. Bentall,et al.  The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia. , 1998, Social science & medicine.

[76]  G. Levin,et al.  Compliance with depot antipsychotic medication by patients attending outpatient clinics. , 1998, Psychiatric services.

[77]  M. Lader.  Pharmacological prevention of relapse. , 1998, The Kaohsiung journal of medical sciences.

[78]  J. Sweeney,et al.  Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. , 1998, Journal of psychiatric research.

[79]  S. Marder.  Facilitating compliance with antipsychotic medication. , 1998, The Journal of clinical psychiatry.

[80]  R. Rosenheck,et al.  Compliance with medication regimens for mental and physical disorders. , 1998, Psychiatric services.

[81]  R. Chaplin,et al.  Informing patients about tardive dyskinesia , 1998, British Journal of Psychiatry.

[82]  B. Puri,et al.  580 Compliance with maintenance medication in first-episode schizophrenia , 1997, Schizophrenia Research.

[83]  R. Heslegrave,et al.  Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse. , 1997, The Journal of nervous and mental disease.

[84]  T. Barnes,et al.  Detecting comorbid substance misuse among people with schizophrenia in the community: a study comparing the results of questionnaires with analysis of hair and urine , 1997, Schizophrenia Research.

[85]  J. Ritchie.  Qualitative Interviewing: The Art of Hearing Data, Herbert J. Rubin and Irene S. Rubin. Thousand Oaks, CA/London/New Delhi: Sage, 1995. 312 pp. £36.95 (hbk); £17.95 (pbk). ISBN: 0-8039-5095-0 (hbk); 0-8039-5096-9 (pbk , 1996 .

[86]  R. Macpherson,et al.  A Controlled Study of Education About Drug Treatment in Schizophrenia , 1996, British Journal of Psychiatry.

[87]  Joseph A. Maxwell,et al.  Qualitative Research Design: An Interactive Approach , 1996 .

[88]  H. Rubin,et al.  Qualitative Interviewing: The Art of Hearing Data , 1995 .

[89]  J. Purvis,et al.  Effects of self medication programme on knowledge of drugs and compliance with treatment in elderly patients , 1995, BMJ.

[90]  R. Liberman,et al.  From compliance to collaboration in the treatment of schizophrenia , 1995, International clinical psychopharmacology.

[91]  M. Ran,et al.  A Controlled Evaluation of Psychoeducational Family Intervention in a Rural Chinese Community , 1994, British Journal of Psychiatry.

[92]  M. Tohen,et al.  One hundred years of schizophrenia: a meta-analysis of the outcome literature. , 1994 .

[93]  M. Phillips,et al.  Family-Based Intervention for Schizophrenic Patients in China , 1994, British Journal of Psychiatry.

[94]  A. Rogers,et al.  Service users' views of psychiatric treatments , 1993 .

[95]  William A. Anthony,et al.  Recovery from mental illness: The guiding vision of the mental health service system in the 1990s. , 1993 .

[96]  C. Waternaux,et al.  One hundred years of schizophrenia: A meta-analysis of the outcome literature , 1993, Schizophrenia Research.

[97]  J. Strauss,et al.  Chronicity in Schizophrenia: Revisited , 1992, British Journal of Psychiatry.

[98]  P. McGorry.  The Concept of Recovery and Secondary Prevention in Psychotic Disorders , 1992, The Australian and New Zealand journal of psychiatry.

[99]  K. Glanz,et al.  Health behavior and health education : theory, research, and practice , 1991 .

[100]  R. Liberman,et al.  From noncompliance to collaboration in the treatment of schizophrenia. , 1990, Hospital & community psychiatry.

[101]  A. David,et al.  Insight and Psychosis , 1990, British Journal of Psychiatry.

[102]  J. Gunderson,et al.  The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. , 1990, Archives of general psychiatry.

[103]  A. Zeichner,et al.  Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report. , 1985, Journal of consulting and clinical psychology.

[104]  T. McGlashan,et al.  Integration and sealing over. Clinically distinct recovery styles from schizophrenia. , 1975, Archives of general psychiatry.

[105]  I. Rosenstock.  Historical Origins of the Health Belief Model , 1974 .

[106]  J. Leff,et al.  Trial of Maintenance Therapy in Schizophrenia* , 1971, British medical journal.

[107]  W. D. Weitzel,et al.  Phenothiazine intake and staff attitudes. , 1971, The American journal of psychiatry.

[108]  A. Strauss,et al.  The discovery of grounded theory: strategies for qualitative research aldine de gruyter , 1968 .

[109]  F. Riessman.  The “Helper” Therapy Principle , 1965 .

[110]  P. Conn,et al.  Emerging approaches for treatment of schizophrenia: modulation of glutamatergic signaling. , 2012, Discovery medicine.

[111]  P. Menezes.  Incidence and Outcome of Schizophrenia Across the Globe , 2010 .

[112]  Julie Kreyenbuhl,et al.  The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. , 2010, Schizophrenia bulletin.

[113]  Nick Barber,et al.  Concordance , adherence and compliance in medicine taking Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation , 2010 .

[114]  F. Dickerson,et al.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. , 2010, Schizophrenia bulletin.

[115]  Haynes Rb,et al.  Interventions for enhancing medication adherence (Review) , 2008 .

[116]  Anuja Roy,et al.  Medication compliance and persistence: terminology and definitions. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[117]  C. Willig.  Introducing qualitative research in psychology : adventures in theory and method , 2008 .

[118]  A. Mitchell.  Adherence behaviour with psychotropic medication is a form of self-medication. , 2007, Medical hypotheses.

[119]  P. Haddad,et al.  Adverse Effects of Atypical Antipsychotics , 2007, CNS drugs.

[120]  P. Masand,et al.  Improving adherence to antipsychotic pharmacotherapy. , 2006, Current clinical pharmacology.

[121]  R. Croyle,et al.  Theory at a glance: a guide for health promotion practice (Second edition). , 2005 .

[122]  M. Valenstein,et al.  Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. , 2004, Schizophrenia bulletin.

[123]  Sharlene Nagy Hesse-Biber,et al.  Approaches to qualitative research : a reader on theory and practice , 2004 .

[124]  M. Wise.  Mad science: discourses of 'schizophrenia'and 'therapy' for hearing voices , 2004 .

[125]  P. Weiden,et al.  Assessment and Treatment Selection for “Revolving Door” Inpatients with Schizophrenia , 2004, Psychiatric Quarterly.

[126]  D. Ezzy.  Qualitative Analysis: Practice and Innovation , 2002 .

[127]  A. David,et al.  Depot antipsychotic medication in the treatment of patients with schizophrenia: (1) meta-review; (2) patient and nurse attitudes. , 2001, Health technology assessment.

[128]  H. Meltzer.  Outcome in schizophrenia: beyond symptom reduction. , 1999, The Journal of clinical psychiatry.

[129]  McEvoy Jp.  Expert Consensus Guideline Series Treatment of Schizophrenia 1999 , 1999 .

[130]  W S Fenton,et al.  Determinants of medication compliance in schizophrenia: empirical and clinical findings. , 1997, Schizophrenia bulletin.

[131]  B. Cuffel.  Comorbid substance use disorder: prevalence, patterns of use, and course. , 1996, New directions for mental health services.

[132]  L. Sperry.  Psychopharmacology and psychotherapy : strategies for maximizing treatment outcomes , 1995 .

[133]  P. Weiden,et al.  Rating of medication influences (ROMI) scale in schizophrenia. , 1994, Schizophrenia bulletin.

[134]  R. Baldessarini.  Enhancing treatment with psychotropic medicines. , 1994, Bulletin of the Menninger Clinic.

[135]  J M Gorman,et al.  Awareness of illness in schizophrenia. , 1991, Schizophrenia bulletin.

[136]  N. Schooler.  Maintenance Medication for Schizophrenia: Strategies for Dose Reduction , 1991 .

[137]  K. Glanz,et al.  Health Behavior and Health Education , 1990 .

[138]  R. Liberman,et al.  A large-scale field test of a medication management skills training program for people with schizophrenia. , 1990 .

[139]  T. Ong.  Depot neuroleptics. , 1989, Singapore medical journal.

[140]  J. Wciórka.  A clinical typology of schizophrenic patients' attitudes towards their illness. , 1988, Psychopathology.

[141]  M. Borenstein,et al.  Compliance in the long-term treatment of schizophrenia. , 1985, Psychopharmacology bulletin.